Curis ticker
WebCuris, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an … WebNov 9, 2024 · The following information was filed by Curis Inc (CRIS) on Wednesday, November 9, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. ... Ticker: CRIS CIK: 1108205 Form Type: 10-Q Quarterly Report Accession Number: 0001108205-22-000023 Submitted to the …
Curis ticker
Did you know?
WebApr 3, 2024 · Curis Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS. 29% … WebDec 7, 2024 · View the latest CRIS stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CURIS, INC..
WebJan 3, 2024 · LEXINGTON, Mass., Jan. 3, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today ... WebAug 18, 2024 · Curis working with clinical sites to resume enrollment. Preliminary clinical data update expected in 2024. LEXINGTON, Mass., Aug. 18, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a ...
WebApr 7, 2024 · Curis, Inc.’s trailing 12-month revenue is $10.2 million with a -557.7% profit margin. Year-over-year quarterly sales growth most recently was -6.5%. Analysts expect adjusted earnings to reach $-0.408 per share for the current fiscal year. Curis, Inc. does not currently pay a dividend. The Biotechnology and Medical Research sub-industry has a ... WebOct 26, 2024 · Curis Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes: Voting Procedures ... Financial Statements, Disclosures …
WebCuris, Inc. - AnnualReports.com More 51-200 Employees Based in Lexington, Massachusetts … More Visit website Most Recent Annual Report MOST RECENT 2024 Annual Report and Form 10K View PDF View Form 10K (HTML)
WebCuris (CRIS) delivered earnings and revenue surprises of 14.29% and 4.72%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for … the pub casinoWebApr 4, 2024 · What is Curis's Market Cap? ( NASDAQ: CRIS) Curis 's market cap is $57.58M, as of Apr 4, 2024. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Curis 's market cap is calculated by multiplying CRIS 's current stock price of $0.60 by CRIS 's total outstanding shares of … the pub centre alWebApr 6, 2024 · Curis Announces Updated Data with Additional Encouraging Clinical Activity in Phase 1/2 Study of CA-4948 Monotherapy in Targeted Patients with Relapsed or … the pub chathamWebThe CURIS Decontamination System is a portable, hydrogen peroxide-based fogging system capable of disinfecting a room or enclosed area via a pulse technology. ... CURIS Decontamination System is private company therefore does not currently have an official ticker symbol. See more information about CURIS Decontamination System. Join the … significance john brown\u0027s raidWebApproved Drug. 1) In April 2024, the U.S. Food and Drug Administration (“FDA”) placed the TakeAim Leukemia study on partial clinical hold. In August 2024, the FDA notified Curis … the pub casino melbourneWebCuris Inc (CRIS) dividend news alerts. Dividend rates, dividend announcements and dates. ... Ticker Symbol Lookup. Quickly find stocks on the NYSE, NASDAQ and more. Curis Inc (CRIS) Dividend News Alerts. CRIS Stock Quote … the pub by novo menuWebPlease Note: All session times for the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics are U.S. Eastern Time (ET). * – short-talk from highly rated proffered paper Thursday, October 7 Poster Sessions9 a.m. (on-demand throughout conference) Educational Sessions10 – 11:20 A.M. EDUCATIONAL SESSION … the pub charles city menu